S. Legrandpoels et al., ACTIVATION OF THE TRANSCRIPTION FACTOR NF-KAPPA-B IN LIPOPOLYSACCHARIDE-STIMULATED U937 CELLS, Biochemical pharmacology, 53(3), 1997, pp. 339-346
During the course of serious bacterial infections, lipopolysaccharide
(LPS) interacts with monocyte/macrophage receptors, resulting in the g
eneration of inflammatory cytokines. Transcription factor NF-kappa B i
s crucial in activating the transcription of genes encoding proinflamm
atory cytokines. In this paper, we demonstrate that the activation of
NF-kappa B by LPS in a promonocytic cell line (U937) followed a rather
slow kinetics, depending on the rate of I kappa B-alpha inhibitor hyd
rolysis. No degradation of p105 and p100 inhibitors was observed under
these conditions. The transduction pathway leading to NF-kappa B acti
vation in U937 cells involved the intracellular generation of reactive
oxygen species (ROS), as demonstrated by the concomitant inhibitory e
ffects of antioxidants on NF-kappa B activation and the emission of a
fluorescent probe reacting intracellularly with hydrogen peroxide. Thi
s ROS pathway was also characterized by the use of other inhibitors. T
his finding indicates that phospholipase A2 and 5-lipoxygenase are als
o involved. However, the NF-kappa B activation pathway involving the a
cidic sphingomyelinase of the endolysosomial membrane did not seem to
participate in the LPS-induced NF-kappa B activation in U937 cells. Co
pyright (C) 1997 Elsevier Science Inc.